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POSTVACCINIAL (INFLUENZA)
DISSEMINATED ENCEPHALOPATHY
(BROWN-SEQUARD SYNDROME)
Suresh J. Antony, MD, FRCP, D. Frank Fleming, MD, and Teresa K. Bradley, MD
Greenville, North Carolina
This article reports a case of Brown-Sequard
syndrome that occurred in a patient following
the administration of trivalent influenza vac-
cine. The patient responded well to intravenous
steroids and physical therapy. This is the first
reported case in the literature. (J Nati Med
Assoc. 1995;87:705-708.)
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Influenza in the United States is a common yet
preventable disease, especially in the population at risk.
The use of the trivalent split vaccine has substantially
reduced the morbidity and mortality of the disease.
These commercially available vaccines have been
associated with relatively few mild adverse reactions.
This article reports the first case of acute disseminated
encephalomyelitis presenting as Brown-Sequard syn-
drome following the administration of trivalent influ-
enza vaccine.
CASE REPORT
A 57-year-old female with a history of thoracic (T6
level) neuritis, right leg paresthesias, and progressive
left leg weakness was admitted to the hospital approxi-
mately 10 days after receiving trivalent influenza
vaccination. In addition, she had developed urinary
retention 24 hours prior to admission.
Her medical history was significant only for a febrile
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reaction to a previous influenza vaccination. There was
no history of drug or egg allergies or recent illnesses.
Medications on admission included estrogen and
medroxyprogesterone acetate. Physical examination
revealed normal vital signs, and the patient was oriented
to time, place, and person. Cranial nerves were intact.
The upper limb strength, sensation, and reflexes were
normal bilaterally. The left lower limb had one-fifth
strength, decreased reflexes, normal sensation, and
upgoing toes. The right limb had normal reflexes and
strength with decreased sensation to pin prick and light
touch extending to T8-T9. Vibration was diminished
below the knees bilaterally with normal position
sensation. Cerebellar testing was grossly normal con-
sidering the weakness of the left leg. Gait was not
assessed accurately due to her inability to stand
independently. The bladder also was noted to be
distended; the rest of the physical examination was
essentially normal.
Laboratory data were unremarkable except for the
cerebrospinal fluid (CSF), in which the total protein
was 34 mg/dL, glucose was 78 mg/dL, 9 red blood
cells/pLL, 15 white blood cells/pLL with 91% lympho-
cytes, 0% polyps, and 9% monocytes. The CSF protein
electrophoresis was normal, and the CSF culture was
negative. Myelin basic protein was 7.8 ng/mL (indeter-
minant). The rheumatoid factor, antinuclear antibodies,
and erythrocyte sedimentation rate were normal, and
the monospot and Lyme antibody titer was negative.
Magnetic resonance imaging (MRI) of the brain
revealed nonspecific white matter changes in the frontal
horns only. Magnetic resonance imaging of the cervical
and thoracic spine revealed abnormal signals with mild
generalized edema in the spinal cord from C3-T5
(Figure 1).
The patient was treated with intravenous steroids for
approximately 8 days, followed by an oral steroid taper
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Figure 1. Magnetic resonance image of the
spinal cord (C3.T5) showing abnormal signals
with edema.
for 10 days, and underwent physical and occupational
therapy. On follow-up, she was found to have improved
strength in the left limb with persistent and sensory
deficits of the right flank and leg. Excellent abductors
and adductors of the thigh were noted, as well as
improved strength in the hip flexors. Hyperesthesia
persisted at the left T9 level. Repeat MRI of the spinal
cord revealed resolution of the edema with improved
patchy hyperintense linear lesions slightly to the left of
the midline from Ti-T4 (Figure 2), which correlates
with the clinical scenario of Brown-Sequard left
thoracic syndrome.
DISCUSSION
Acute disseminated encephalomyelitis following
vaccination and various infections was first described
Figure 2. Magnetic resonance image of the
spinal cord (TI 5) showing resolving linear
lesions to the left of the midline with resolving
edema.
by DeVries in 1960. He descnbed characteristic
pathologic penvenous demyelination in one group and
nonspecific changes without demyelination in another
group, which usually presented as encephalitis.2-4
However, since the introduction of the purified trivalent
influenza split vaccine in the 1970s, these side effects
have been reduced in severity.5^9
The Centers for Disease Control suggest that the
following groups be immunized: 10-11
* adults and children with chronic cardiovascular and
pulmonary disorders,
* residents of nursing homes and other chronic-care
facilities,
* medical personnel who have extensive contact with
high-risk patients, and
* individuals over 65 years of age and adults and
children with chronic metabolic illnesses such as
renal failure, immunosuppression, and asthma. '12
Vaccination for influenza is thought to provide at
least 70% protection once the patient has responded
with antibody production (usually 2 weeks after
immunization). In addition, it is important to note that
the antigenic variation is revised annually by the Food
and Drug Administration to include the antigen that is
most likely to be prevalent at that time.12 The trivalent
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vaccine used currently contains two strains of influenza
A and one of influenza B.
Acute disseminated encephalomyelitis has been
reported following rabies vaccination and the use of
drugs such as streptomycin and paraaminosalycyclic
acid (PAS).13 Guillian Barre syndrome was reported in
1 out of 100 000 during the vaccination for the swine
epidemic in 1976, with 1 out of 2 million persons dying
of Guillian Bar Syndrome during this epidemic. This
was seen only in adults and has not been reported
subsequently. 14,15
Several studies have noted adverse effects of the
influenza vaccination including flu-like illness, coryza,
cough, fatigue, myalgias, and headaches.7'8 There was
no serious neurological reaction reported in recent
studies.6'7"16"17
Adverse reactions to the vaccination can be classified
as:
* toxic, which includes myalgia and fever and occurs
in the range of 5% to 7%,18-20
* allergic reactions such as urticaria and anaphylaxis,
which are relatively rare since the introduction of the
new purified vaccine, or
* neurological events such as encephalitis, which
occurred with the previous vaccine.2-4
Review of the recent literature is sparse and includes
a case of acute cerebellar ataxia in a child following the
vaccination.21 Wells4 also reported two cases of
myelitis and one case of neuropathy following vaccina-
tion. Our patient presented with neurological findings
suggestive of Brown-Sequard syndrome or a variant of
acute disseminated encephalomyelitis.
Most patients who present with acute disseminated
encephalomyelitis have a history of recent viral illness
such as measles, influenza, herpes simplex, or foreign
antigen exposure, such as vaccination.22 The illness
usually presents with constitutional symptoms, fol-
lowed by a latent period, and then focal or widespread
central nervous system involvement, such as meningi-
tis, pyramidal tract involvement, sensory and cerebellar
involvement, motor disorders, and even seizures.23 This
patient presented with both pyramidal and sensory tract
involvement that resembled a Brown-Sequard syn-
drome.24-26
Diagnosis of these patients consists of examination
of the CSF, which may have a slightly elevated protein
and pressure. However, it may be completely normal in
up to 30% of the cases.23 Electroencephalograms are
nonspecific and thus have limited value. The most
useful test in this condition would be MRI, as
demonstrated in Figures 1 and 2.
Management of postvaccinial acute disseminated
encephalomyelitis has not been studied extensively due
to the rarity of the condition. As noted in this patient,
the use of standard doses of steroids (0.5 to 1.0 mg/kg)
during the acute phase, followed by a steroid taper
appears to be somewhat effective. In addition, physio-
therapy and occupational therapy also would be
beneficial. Recovery tends to be prolonged, but com-
plete.
SUMMARY
The patient reported here had no prior illnesses or
allergies, and the time interval between the vaccination
and the illness is compatible with a direct relationship,
although this cannot be proven. This case report
suggests that severe neurological defects are possible
with this trivalent vaccine but that they are rare.
Physicians must be aware of this possibility when
evaluating such unusual presentations.
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